Free Trial

Vivos Q4 2023 Earnings Report

Vivos logo
$0.12 +0.01 (+5.59%)
As of 02/21/2025 03:56 PM Eastern

Vivos EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Vivos Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vivos Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Vivos Earnings Headlines

Your trading day could end at 11 AM
What do you usually do between 9:35 AM and 11:00 AM? Catch up on emails? Attend a meeting? Maybe grab a coffee? For me, it's become the most important part of my trading day. 85 minutes. That's usually all it takes. Set up at 9:35 AM… Check back at 11:00 AM. And when things work out, there's an extra $100 to $150 in my account… on a $1000 starting stake. Sounds too simple, doesn't it?
See More Vivos Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vivos? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vivos and other key companies, straight to your email.

About Vivos

Vivos (OTCMKTS:RDGL), a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington.

View Vivos Profile

More Earnings Resources from MarketBeat